Madison Park Capital Advisors LLC Takes $34,000 Position in American Well Co. (NYSE:AMWL)

Madison Park Capital Advisors LLC purchased a new stake in American Well Co. (NYSE:AMWL) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 22,906 shares of the company’s stock, valued at approximately $34,000.

Several other institutional investors and hedge funds also recently made changes to their positions in AMWL. Senvest Management LLC boosted its position in shares of American Well by 3.7% during the 3rd quarter. Senvest Management LLC now owns 23,022,624 shares of the company’s stock valued at $26,936,000 after purchasing an additional 813,244 shares in the last quarter. GSA Capital Partners LLP lifted its holdings in shares of American Well by 75.5% in the third quarter. GSA Capital Partners LLP now owns 716,830 shares of the company’s stock valued at $839,000 after purchasing an additional 308,418 shares in the last quarter. Swiss National Bank lifted its holdings in shares of American Well by 2.3% in the third quarter. Swiss National Bank now owns 463,200 shares of the company’s stock valued at $542,000 after purchasing an additional 10,500 shares in the last quarter. Versor Investments LP bought a new position in shares of American Well in the third quarter valued at approximately $294,000. Finally, Barclays PLC lifted its holdings in shares of American Well by 8.8% in the third quarter. Barclays PLC now owns 173,359 shares of the company’s stock valued at $203,000 after purchasing an additional 14,021 shares in the last quarter. Institutional investors and hedge funds own 56.05% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Morgan Stanley dropped their target price on American Well from $1.75 to $1.00 and set an “equal weight” rating on the stock in a report on Monday, April 15th.

Insider Activity at American Well

In related news, insider Kathy Johnson Weiler sold 283,192 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $1.09, for a total transaction of $308,679.28. Following the completion of the sale, the insider now directly owns 3,975,617 shares of the company’s stock, valued at $4,333,422.53. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other American Well news, EVP Vukasin Paunovich sold 251,323 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $1.09, for a total value of $273,942.07. Following the completion of the sale, the executive vice president now directly owns 2,535,635 shares of the company’s stock, valued at $2,763,842.15. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Kathy Johnson Weiler sold 283,192 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $1.09, for a total value of $308,679.28. Following the completion of the sale, the insider now directly owns 3,975,617 shares of the company’s stock, valued at $4,333,422.53. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,169,038 shares of company stock valued at $1,267,410. 12.94% of the stock is owned by insiders.

American Well Price Performance

Shares of AMWL stock traded down $0.01 during trading hours on Tuesday, reaching $0.54. The company had a trading volume of 2,396,099 shares, compared to its average volume of 1,944,208. American Well Co. has a 12 month low of $0.50 and a 12 month high of $2.74. The business has a fifty day simple moving average of $0.88 and a 200-day simple moving average of $1.09. The company has a market cap of $156.66 million, a price-to-earnings ratio of -0.23 and a beta of 1.00.

American Well (NYSE:AMWL) last issued its quarterly earnings results on Wednesday, February 14th. The company reported ($0.17) EPS for the quarter, beating analysts’ consensus estimates of ($0.19) by $0.02. The company had revenue of $70.68 million during the quarter, compared to the consensus estimate of $70.16 million. American Well had a negative return on equity of 40.19% and a negative net margin of 260.63%. American Well’s revenue was down 10.8% on a year-over-year basis. During the same period last year, the business posted ($0.22) earnings per share. On average, equities research analysts expect that American Well Co. will post -0.7 earnings per share for the current year.

American Well Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.